title: Efficacy and tolerance of nisoldipine VS propranolol in patients with essential hypertension.
abstract: Fifty patients with essential hypertension grade I/II. (WHO) were treated with Nisoldipine (BAY K 5552) or Propranolol for 12 weeks in a single blind, randomised trial. Both drugs similarly reduced mean systolic and diastolic blood pressure. Side effects were rare and usually mild. We conclude that Nisoldipine is safe and effective in the treatment of mild essential hypertension.
authors: II Department of Cardiology, Grochowski Hospital, Warszawa, Poland.
authors: T
authors: T
authors: Chamiec
authors: B
authors: B
authors: Bednarz
authors: A
authors: A
authors: Budaj
authors: J
authors: J
authors: Kłoś
authors: H
authors: H
authors: Pietrzykowska
authors: T
authors: T
authors: Zaleska
authors: L
authors: L
authors: Ceremuzyński
mesh_terms: D001794:Blood Pressure / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008875:Middle Aged; D015737:Nisoldipine / Q000009:adverse effects / Q000627:therapeutic use*; D011433:Propranolol / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D015737:Nisoldipine; D011433:Propranolol